Skip to content
ClinCalc Pro
Menu
Direct Vasodilator (NO Donor) — Hypertensive Emergency / Aortic Dissection

Sodium Nitroprusside

Brand names: Nitropress, Nipride

Sodium nitroprusside is a potent, rapidly acting intravenous vasodilator given by continuous infusion for hypertensive emergencies and for controlled hypotension during surgery, used in a monitored setting.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It releases nitric oxide, which raises cyclic GMP in vascular smooth muscle to produce balanced arterial and venous dilatation, lowering both preload and afterload almost immediately.

Prescribing in practice

  • Prolonged or high-rate infusion risks accumulation of cyanide and thiocyanate metabolites causing potentially fatal toxicity, so limit duration and rate, and use cyanide antidotes if toxicity is suspected — risk is greater in hepatic or renal impairment.
  • It must be given by titrated infusion with continuous arterial blood pressure monitoring because hypotension is rapid in onset and offset, and the solution and giving set must be protected from light.
  • Avoid in compensatory hypertension (such as coarctation), severe vitamin B12 deficiency and Leber's optic atrophy.

Monitoring

Monitor blood pressure continuously, ideally intra-arterially, and watch for metabolic acidosis or rising thiocyanate as markers of cyanide accumulation during prolonged infusion.

Counselling the patient

  • Explain this is a short-acting drip used to control blood pressure precisely.
  • It is given only with close monitoring and the dose is adjusted minute to minute.

Evidence & guidelines

Its role in hypertensive emergencies and controlled hypotension is long-established and supported by the SPC and critical care references.

Reference: ESC Aortic Disease Guidelines 2014; AHA/ACC Hypertensive Crisis Guidelines; MHRA SPC Nitropress; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.